# Efficacy and Safety of GENOSS® SES in Patients With Acute Coronary Syndrome (GENOSS ACS)

> **NCT06075368** · — · ACTIVE_NOT_RECRUITING · sponsor: **Genoss Co., Ltd.** · enrollment: 757 (actual)

## Conditions studied

- Acute Coronary Syndrome
- Percutaneous Coronary Intervention

## Interventions

- **DEVICE:** GENOSS Sirolimus Eluting Coronary Stent System

## Key facts

- **NCT ID:** NCT06075368
- **Lead sponsor:** Genoss Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-03-16
- **Primary completion:** 2025-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 757 (ACTUAL)
- **Last updated:** 2026-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06075368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06075368, "Efficacy and Safety of GENOSS® SES in Patients With Acute Coronary Syndrome (GENOSS ACS)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06075368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*